Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.
Journal: Blood cancer journal
Published: January 11, 2025
Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies.
Journal: European journal of haematology
Published: December 05, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Journal: British journal of haematology
Published: June 13, 2024
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
Journal: American journal of hematology
Published: January 19, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Journal: Blood cancer journal
Published: November 30, 2023
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells.
Journal: The Journal of clinical investigation
Published: November 29, 2021
Conservation of cell-intrinsic immune responses in diverse nonhuman primate species.
Journal: Life science alliance
Published: July 20, 2019
Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 20, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026